Subheading · Chapter 30 · Heading 3002
3002.51: Cell cultures, whether or not modified: cell therapy products
Cell therapy products
Official description Cell therapy products
3002.51 is the HS subheading for cell therapy products, under heading 3002 in chapter 30.
What you pay
Importing into UK
Rates by national line · UK Global Tariff
UK lines →- 3002 51 00 00 Cell therapy products Free
Additional duties and import rules
Charges on top of the customs duty, and rules the goods must meet at the border.
Additional duties and charges 1
- Additional dutyAdditional duties 35%
- Applies to goods from
- Belarus, Russia
- Legal act
- 2022 No. 598
- Documents
- 9014
Import requirements 1
- Import controlRestriction on entry into free circulation
- Applies to goods from
- Ukraine
- Legal act
- S.I. 2022/395
- Documents
- 9009
- 9010
- 9017
Preferential rates by country
| Agreement or scheme | Countries | Rate |
|---|---|---|
| standard rate (no agreement) | — | Free |
| DCTS Comprehensive | Afghanistan, Angola, Bangladesh, Benin and 38 moreAfghanistan, Angola, Bangladesh, Benin, Bhutan, Burkina Faso, Burundi, Cambodia, Central African Republic, Chad, Comoros, Congo - Kinshasa, Djibouti, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Kiribati, Laos, Liberia, Malawi, Mali, Mauritania, Myanmar (Burma), Nepal, Niger, Rwanda, São Tomé & Príncipe, Senegal, Sierra Leone, Somalia, South Sudan, Sudan, Tanzania, Timor-Leste, Togo, Tuvalu, Uganda, Yemen, Zambia | Free |
| European Union (including code " EU") | Free | |
| CARIFORUM | Antigua & Barbuda, Bahamas, Barbados, Belize and 10 moreAntigua & Barbuda, Bahamas, Barbados, Belize, Dominica, Dominican Republic, Grenada, Guyana, Jamaica, St Kitts & Nevis, St Lucia, St Vincent & the Grenadines, Suriname, Trinidad & Tobago | Free |
| OCTs (Overseas Countries and Territories) | Anguilla, Bermuda, British Indian Ocean Territory, British Virgin Islands and 7 moreAnguilla, Bermuda, British Indian Ocean Territory, British Virgin Islands, Cayman Islands, Falkland Islands, Montserrat, Pitcairn Islands, South Georgia & South Sandwich Islands, St Helena, Turks & Caicos Islands | Free |
| Central America | Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama | Free |
| SADC EPA | Botswana, Eswatini, Lesotho, Mozambique, Namibia | Free |
| Eastern and Southern Africa States | Madagascar, Mauritius, Seychelles, Zimbabwe | Free |
| CPTPP | Brunei, Malaysia | Free |
| UK–Andorra agreement | Andorra | Free |
| UK–Albania agreement | Albania | Free |
| UK–Australia agreement | Australia | Free |
| UK–Canada agreement | Canada | Free |
| UK–Switzerland agreement | Switzerland | Free |
| UK–Côte d’Ivoire agreement | Côte d’Ivoire | Free |
| UK–Chile agreement | Chile | Free |
| UK–Cameroon agreement | Cameroon | Free |
| UK–Colombia agreement | Colombia | Free |
| UK–Ceuta & Melilla agreement | Ceuta & Melilla | Free |
| UK–Ecuador agreement | Ecuador | Free |
| UK–Egypt agreement | Egypt | Free |
| UK–Fiji agreement | Fiji | Free |
| UK–Faroe Islands agreement | Faroe Islands | Free |
| UK–Georgia agreement | Georgia | Free |
| UK–Ghana agreement | Ghana | Free |
| UK–Israel agreement | Israel | Free |
| UK–India agreement | India | Free |
| UK–Iceland agreement | Iceland | Free |
| UK–Jordan agreement | Jordan | Free |
| UK–Japan agreement | Japan | Free |
| UK–Kenya agreement | Kenya | Free |
| UK–South Korea agreement | South Korea | Free |
| UK–Lebanon agreement | Lebanon | Free |
| UK–Liechtenstein agreement | Liechtenstein | Free |
| UK–Morocco agreement | Morocco | Free |
| UK–Moldova agreement | Moldova | Free |
| UK–North Macedonia agreement | North Macedonia | Free |
| UK–Mexico agreement | Mexico | Free |
| UK–Norway agreement | Norway | Free |
| UK–New Zealand agreement | New Zealand | Free |
| UK–Peru agreement | Peru | Free |
| UK–Papua New Guinea agreement | Papua New Guinea | Free |
| UK–Palestinian Territories agreement | Palestinian Territories | Free |
| UK–Serbia agreement | Serbia | Free |
| UK–Solomon Islands agreement | Solomon Islands | Free |
| UK–Singapore agreement | Singapore | Free |
| UK–San Marino agreement | San Marino | Free |
| UK–Tunisia agreement | Tunisia | Free |
| UK–Türkiye agreement | Türkiye | Free |
| UK–Ukraine agreement | Ukraine | Free |
| UK–Vietnam agreement | Vietnam | Free |
| UK–Samoa agreement | Samoa | Free |
| UK–Kosovo agreement | Kosovo | Free |
| UK–South Africa agreement | South Africa | Free |
UK: imports by month
Main suppliers, last 12 months
| Country | Value | Share | Change |
|---|---|---|---|
| £51.2m | 51.1% | -0.8% | |
| £26.9m | 26.9% | +162.3% | |
| £13m | 13% | +1,605.1% | |
| £4m | 4% | -1.4% | |
| £2.8m | 2.8% | +11.9% | |
| £1.7m | 1.7% | +238.8% | |
| £318k | 0.3% | +1.4% | |
| £182k | 0.2% | +38.9% |
Same subheading in other tariffs
World trade in 2024
Trade value (US$) no reported trade < US$91kUS$91k+US$5m+US$22m+> US$421m
Exports: 47
- United States: US$875m
- Netherlands: US$421m
- Switzerland: US$219m
- Germany: US$199m
- United Kingdom: US$22m
- Spain: US$17m
- Ireland: US$15m
- Austria: US$9m
- France: US$8m
- Italy: US$7m
- South Korea: US$5m
- Israel: US$3m
- Australia: US$1m
- Belgium: US$1m
- Sweden: US$1m
- Denmark: US$630k
- Saudi Arabia: US$543k
- China: US$484k
- Singapore: US$261k
- Iceland: US$209k
- India: US$97k
- Hong Kong SAR China: US$91k
- Canada: US$75k
- Japan: US$66k
- South Africa: US$54k
- Türkiye: US$50k
- Taiwan: US$41k
- Latvia: US$33k
- Hungary: US$29k
- Malaysia: US$29k
- Portugal: US$18k
- Poland: US$12k
- Ukraine: US$5k
- Lithuania: US$4k
- Norway: US$4k
- Finland: US$3k
- Indonesia: US$2k
- Slovakia: US$1k
- Czechia: US$400
- Kazakhstan: US$300
- Estonia: US$200
- Luxembourg: US$100
- Romania: US$100
- Kyrgyzstan: US$0
- Russia: US$0
- Thailand: US$0
- Vietnam: US$0
Trade value (US$) no reported trade < US$196kUS$196k+US$14m+US$49m+> US$215m
Imports: 84
- Germany: US$450m
- France: US$244m
- Japan: US$215m
- Spain: US$94m
- United Kingdom: US$88m
- Canada: US$86m
- Austria: US$52m
- Poland: US$49m
- Italy: US$49m
- Saudi Arabia: US$48m
- Ireland: US$46m
- Switzerland: US$43m
- Australia: US$40m
- South Korea: US$34m
- Netherlands: US$33m
- Israel: US$33m
- Czechia: US$29m
- United States: US$25m
- Slovenia: US$17m
- Slovakia: US$16m
- Sweden: US$14m
- Taiwan: US$12m
- Portugal: US$11m
- Belgium: US$10m
- Brazil: US$10m
- Norway: US$9m
- Hong Kong SAR China: US$8m
- Finland: US$7m
- Croatia: US$7m
- Denmark: US$7m
- Singapore: US$4m
- Romania: US$4m
- Serbia: US$3m
- Luxembourg: US$1m
- Hungary: US$1m
- Bahamas: US$699k
- Türkiye: US$692k
- Greece: US$672k
- Kuwait: US$334k
- China: US$260k
- Colombia: US$209k
- India: US$196k
- New Zealand: US$125k
- Malaysia: US$117k
- El Salvador: US$86k
- Iceland: US$81k
- New Caledonia: US$77k
- Maldives: US$61k
- Wallis & Futuna: US$57k
- Ukraine: US$57k
- Malawi: US$50k
- Lithuania: US$46k
- Qatar: US$42k
- Indonesia: US$38k
- Azerbaijan: US$28k
- Sri Lanka: US$26k
- Philippines: US$23k
- Bosnia & Herzegovina: US$22k
- Thailand: US$19k
- Côte d’Ivoire: US$16k
Top exporters
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | US$875m | 48.5% | |
| 2 | US$421m | 23.3% | |
| 3 | US$219m | 12.1% | |
| 4 | US$199m | 11% | |
| 5 | US$22m | 1.2% | |
| 6 | US$17m | 0.9% | |
| 7 | US$15m | 0.8% | |
| 8 | US$9m | 0.5% | |
| 9 | US$8m | 0.4% | |
| 10 | US$7m | 0.4% |
Top importers
| Rank | Country | Value | Share |
|---|---|---|---|
| 1 | US$450m | 24.9% | |
| 2 | US$244m | 13.5% | |
| 3 | US$215m | 11.9% | |
| 4 | US$94m | 5.2% | |
| 5 | US$88m | 4.9% | |
| 6 | US$86m | 4.8% | |
| 7 | US$52m | 2.9% | |
| 8 | US$49m | 2.7% | |
| 9 | US$49m | 2.7% | |
| 10 | US$48m | 2.7% |
Import duty on this product around the world 93
The most-favoured-nation (MFN) duty each country applies to goods of this HS subheading: the average over its national tariff lines, with the lowest and highest line where they differ. Goods from countries with a trade agreement often pay less.
- 0%median duty
- 77number of duty-free countries (MFN)
- 15%highest: French Polynesia, Pakistan, India
93
| Importing country | MFN duty | lines from – to | data year |
|---|---|---|---|
| 0% | 2023 | ||
| 5% | 2023 | ||
| 6.5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2022 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2022 | ||
| 5% | 2022 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 5% | 2023 | ||
| 3% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2022 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 15% | 2023 | ||
| 5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 10% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 5% | 2023 | ||
| 2.5% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 11% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 3% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 | ||
| 0% | 2023 |
Tariff data years 2022–2023; rates may have changed since. · UNCTAD TRAINS, accessed via WITS (World Bank)
Classifications and correspondences
Where this HS subheading sits in the United Nations' statistical classifications, and which codes it had in earlier editions of the Harmonized System.
- SITC Rev. 4
- 54164 Human blood; animal blood prepared for therapeutic, prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excluding yeasts) & similar products
- End use (BEC Rev. 5)
- Intermediate goods · BEC 711220
- CPC 2.1 product
- 35270 Other pharmaceutical products
- ISIC Rev. 4 activity
- 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products
Earlier HS editions
| HS | Code | |
|---|---|---|
| 2017 | 3002.90 | changed |
| 2012 | 3002.90 | changed |
| 2007 | 2933.29, 3002.10, 3002.90 | changed |
| 2002 | 2933.29, 3002.10, 3002.90 | changed |
| 1996 | 2933.29, 3002.10, 3002.90 | changed |
| 1992 | 2933.29, 3002.10, 3002.90 | changed |
Correspondence tables of the United Nations Statistics Division (UNSD)
Binding rulings for similar goods 5
Decisions of U.S. Customs and Border Protection (CROSS) and HMRC (Advance Tariff Rulings) on goods classified here. A ruling binds only its holder, but shows how the authorities classify similar goods. The descriptions are the authorities’ own, in English.
- N325758 U.S. CBP
The tariff classification of YESCARTA® (Axicabtagene Ciloleucel) from the Netherlands
- 600011117 HMRC
modified lymphocytes Use: treatment of patients, in clinical trials or commercially marketed cryopreserved for transportation and importation purposes
- 600011118 HMRC
modified lymphocytes Use: treatment of patients, in clinical trials or commercially marketed cryopreserved for transportation and importation purposes
- 600010909 HMRC
modified lymphocytes Use: treatment of patients, in clinical trials or commercially marketed cryopreserved for transportation and importation purposes
- 600010993 HMRC
modified lymphocytes Use: treatment of patients, in clinical trials or commercially marketed cryopreserved for transportation and importation purposes
Recent rule changes mentioning this code
Acts whose text cites this code or its heading. Check the act itself: a code can be cited for reasons other than a change of its duty.
-
FR Doc. 2026-19498 · 91 FR 60360 · Source: federalregister.gov
-
FR Doc. 2026-14542 · 91 FR 45516 · Source: federalregister.gov
-
FR Doc. 2026-11158 · 91 FR 33854 · Source: federalregister.gov
-
CELEX 32026R0360 · Source: eur-lex.europa.eu
Code history
Since 2022; before, these goods were classified under 3002.90.
Subheading 3002.51 is a single line in the UK Global Tariff, where the duty is duty-free.
The EU Combined Nomenclature has one tariff line for subheading 3002.51; the duty is duty-free.
Goods from 156 countries can enter the UK at a preferential rate instead of the standard Free; 156 of them pay no duty at all, for example under DCTS Comprehensive or European Union.
In the UK, additional duty of 35% applies on top of the customs duty to goods from Belarus and Russia.
In the 12 months to August 2026, the UK imported cell therapy products worth £100.2m (up 42% on the year before), at an average of £7,789.74 per kg; Netherlands supplied 51%, followed by United States.
World trade in cell therapy products reached US$2bn in 2024, up 29.4% on 2023.
The United States was the largest exporter with 48.5% of the total, ahead of the Netherlands.
Questions and answers
What is the HS code for cell cultures, whether or not modified: cell therapy products?
Cell cultures, whether or not modified: cell therapy products fall under HS subheading 3002.51, part of heading 3002, in section VI of the Harmonized System.
What is the import duty on cell cultures in the UK?
Under the UK Global Tariff, imports under 3002.51 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
What is the import duty on cell cultures in the EU?
Under the EU Combined Nomenclature, imports under 3002.51 from countries without a preferential agreement are free of duty. Preferential rates, anti-dumping duties and VAT are not included.
Which country exports the most cell cultures?
The United States, with US$875m in 2024 (48.5% of world exports).
Which countries can export cell therapy products to the UK duty-free?
156 countries pay no duty under a trade agreement or preference scheme, among them partners under DCTS Comprehensive, European Union, CARIFORUM. The goods must meet the agreement’s rules of origin and the importer needs proof of origin; otherwise the standard rate of Free applies. Pick a country above to see its rate.
Is there anti-dumping duty on cell therapy products?
The UK charges additional duty of 35% on goods from Belarus and Russia. Lower rates apply to the named exporters listed in the measure.
Where does the UK import cell therapy products from?
In the 12 months to August 2026, the largest suppliers were Netherlands (51%), United States (27%) and Ireland (13%), out of total imports of £100.2m.